Targeting BCMA in Myeloma: Expert Insight on Novel Therapies

Review this expert-authored educational program to gain insights on how BCMA-targeted agents might benefit patients with myeloma in your clinical practice and download the slides for discussion with your colleagues!

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Celgene